Literature DB >> 16299238

Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.

Jin-Yuan Shih1, Meng-Feng Tsai, Tzu-Hua Chang, Yih-Leong Chang, Ang Yuan, Chong-Jen Yu, Shin-Bey Lin, Geou-Yarh Liou, Meng-Larn Lee, Jeremy J W Chen, Tse-Ming Hong, Shuenn-Chen Yang, Jen-Liang Su, Yung-Chie Lee, Pan-Chyr Yang.   

Abstract

PURPOSE: In a previous genome-wide gene expression profiling analysis using an invasion cancer cell lines model, we have identified Slug as selectively overexpressed in the highly invasive cancer cells. Here, we investigated the clinical significance of Slug in lung adenocarcinoma and the role of Slug in the process of cancer cell invasion and metastasis. EXPERIMENTAL
DESIGN: Real-time quantitative reverse transcription-PCR was used to investigate Slug mRNA in surgically resected lung adenocarcinoma of 54 patients and its correlation with survival. We overexpressed Slug in a lung adenocarcinoma cell line with very low Slug levels and investigated the in vitro and in vivo effects of Slug expression.
RESULTS: High expression of Slug mRNA in lung cancer tissue was significantly associated with postoperative relapse (P = 0.03) and shorter patient survival (P < 0.001). The overexpression of Slug enhanced xenograft tumor growth and increased microvessel counts in angiogenesis assay. Both inducible and constitutive overexpression of Slug suppressed the expression of E-cadherin and increased the in vitro invasive ability. Zymography revealed increased matrix metalloproteinase-2 activity in Slug overexpressed cells. ELISA, reverse transcription-PCR, and immunohistochemistry confirmed the increase of matrix metalloproteinase-2 proteins and mRNA in Slug overexpressed cells and xenograft tumors.
CONCLUSIONS: Slug expression can predict the clinical outcome of lung adenocarcinoma patients. Slug is a novel invasion-promoting gene in lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299238     DOI: 10.1158/1078-0432.CCR-05-0687

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  98 in total

1.  Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.

Authors:  Ke-Jun Zhang; Bing-Yuan Zhang; Kun-Peng Zhang; Li-Min Tang; Shi-Song Liu; Dong-Ming Zhu; Dian-Liang Zhang
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis.

Authors:  Vahab D Soleimani; Hang Yin; Arezu Jahani-Asl; Hong Ming; Christel E M Kockx; Wilfred F J van Ijcken; Frank Grosveld; Michael A Rudnicki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

Review 3.  Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.

Authors:  Duane H Hamilton; Mary T Litzinger; Romaine I Fernando; Bruce Huang; Claudia Palena
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

4.  A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.

Authors:  C-H Chen; P Thai; K Yoneda; K B Adler; P-C Yang; R Wu
Journal:  Oncogene       Date:  2013-08-19       Impact factor: 9.867

Review 5.  Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells.

Authors:  Claudia Palena; Romaine I Fernando; Mary T Litzinger; Duane H Hamilton; Bruce Huang; Jeffrey Schlom
Journal:  Exp Biol Med (Maywood)       Date:  2011-03-22

6.  Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

Authors:  Tsang-Chih Kuo; Ching-Ting Tan; Yi-Wen Chang; Chih-Chen Hong; Wei-Jiunn Lee; Min-Wei Chen; Yung-Ming Jeng; Jean Chiou; Pei Yu; Pai-Sheng Chen; Ming-Yang Wang; Michael Hsiao; Jen-Liang Su; Min-Liang Kuo
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

Review 7.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer.

Authors:  Yubo Zhai; Julia Santucci-Pereira; Ricardo Lopez de Cicco; Irma H Russo; Jose Russo
Journal:  Drug Discov Today Dis Mech       Date:  2012

9.  p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug.

Authors:  Shu-Ping Wang; Wen-Lung Wang; Yih-Leong Chang; Chen-Tu Wu; Yu-Chih Chao; Shih-Han Kao; Ang Yuan; Chung-Wu Lin; Shuenn-Chen Yang; Wing-Kai Chan; Ker-Chau Li; Tse-Ming Hong; Pan-Chyr Yang
Journal:  Nat Cell Biol       Date:  2009-05-17       Impact factor: 28.824

10.  SNAI2/Slug promotes growth and invasion in human gliomas.

Authors:  Hong Wei Yang; Lata G Menon; Peter M Black; Rona S Carroll; Mark D Johnson
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.